MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$6.97 USD
-0.18 (-2.52%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $6.97 0.00 (0.00%) 5:40 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, MiMedx Group, Inc has a market cap of $1.06B, which represents its share price of $7.15 multiplied by its outstanding shares number of 147.96M. As a small-cap company, MDXG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MDXG 6.97 -0.18(-2.52%)
Will MDXG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MDXG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDXG
MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?
MDXG: What are Zacks experts saying now?
Zacks Private Portfolio Services
MiMedx (MDXG) Q1 Earnings Match Estimates
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates
Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength?
Other News for MDXG
MiMedx Group Breaks Above 200-Day Moving Average - Bullish for MDXG
Decoding MiMedx Group Inc (MDXG): A Strategic SWOT Insight
MiMedx Group (MDXG) Target Price Raised by Cantor Fitzgerald | MDXG Stock News
MiMedx (MDXG) Price Target Raised by Cantor Fitzgerald
MiMedx price target raised by $1 at Cantor Fitzgerald, here's why